Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension

British Journal of Haematology

Volumn 149, Issue 3, 2010, Pages 436-445

  Zorca, Suzana ^a   Freeman, Lita ^a   Hildesheim, Mariana ^b   Allen, Darlene ^a   Remaley, Alan T ^a   Taylor VI, James G ^a   Kato, Gregory J ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cholesterol; Haemolysis; Pulmonary hypertension; Sickle cell disease; Triglycerides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ARGINASE; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANEMIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOREARM BLOOD FLOW; HEMOLYSIS; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PH; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SICKLE CELL ANEMIA; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ADULT; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; ENDOTHELIUM, VASCULAR; FEMALE; HEMOLYSIS; HUMANS; HYPERTENSION, PULMONARY; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 77950836937     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08109.x     Document Type: Article

References (50)

1. Adedeji, M.O., Cespedes, J., Allen, K., Subramony, C. Hughson, M.D. (2001) Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Archives of Pathology and Laboratory Medicine, 125, 1436 1441.
2. Akinyanju, P.A. Akinyanju, C.O. (1976) Plasma and red cell lipids in sickle cell disease. Annals of Clinical and Laboratory Science, 6, 521 524.
3. Amarenco, P. Labreuche, J. (2009) Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurology, 8, 453 463.
4. Aslan, M., Ryan, T.M., Adler, B., Townes, T.M., Parks, D.A., Thompson, J.A., Tousson, A., Gladwin, M.T., Patel, R.P., Tarpey, M.M., Batinic-Haberle, I., White, C.R. Freeman, B.A. (2001) Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proceedings of the National Academy of Sciences of the United States of America, 98, 15215 15220.
5. Ataga, K.I., Moore, C.G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A. Orringer, E.P. (2006) Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. British Journal of Haematology, 134, 109 115.
6. Belcher, J.D., Marker, P.H., Geiger, P., Girotti, A.W., Steinberg, M.H., Hebbel, R.P. Vercellotti, G.M. (1999) Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. Journal of Laboratory and Clinical Medicine, 133, 605 612.
7. Boyanovsky, B.B. Webb, N.R. (2009) Biology of secretory phospholipase A2. Cardiovascular Drugs and Therapy, 23, 61 72.
8. Buchowski, M.S., Swift, L.L., Akohoue, S.A., Shankar, S.M., Flakoll, P.J. Abumrad, N. (2007) Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease. Journal of Parenteral and Enteral Nutrition, 31, 263 268.
9. Choy, E. Sattar, N. (2009) Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Annals of the Rheumatic Diseases, 68, 460 469.
10. Galie, N., Manes, A., Farahani, K.V., Pelino, F., Palazzini, M., Negro, L., Romanazzi, S. Branzi, A. (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus, 14, 713 717.
11. Gladwin, M.T., Schechter, A.N., Ognibene, F.P., Coles, W.A., Reiter, C.D., Schenke, W.H., Csako, G., Waclawiw, M.A., Panza, J.A. Cannon, III., R.O. (2003) Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation, 107, 271 278.
12. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886 895.
13. Gotto, A.M.M. Pownall, H.J. (2003) Manual of Lipid Disorders: Reducing the Risk for Coronary Heart Disease. Lippincott, Williams and Wilkins
14. Graham, J.K., Mosunjac, M., Hanzlick, R.L. Mosunjac, M. (2007) Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review. American Journal of Forensic Medicine and Pathology, 28, 168 172.
15. Haque, A.K., Gokhale, S., Rampy, B.A., Adegboyega, P., Duarte, A. Saldana, M.J. (2002) Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Human Pathology, 33, 1037 1043.
16. el-Hazmi, M.A., Jabbar, F.A. Warsy, A.S. (1987) Cholesterol and triglyceride level in patients with sickle cell anaemia. Scandinavian Journal of Clinical and Laboratory Investigation, 47, 351 354.
17. el-Hazmi, M.A., Warsy, A.S., al-Swailem, A., al-Swailem, A. Bahakim, H. (1995) Red cell genetic disorders and plasma lipids. Journal of Tropical Pediatrics, 41, 202 205.
18. Hebbel, R.P., Osarogiagbon, R. Kaul, D. (2004) The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation, 11, 129 151.
19. Kato, G.J. Gladwin, M.T. (2008) Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. Journal of the American Medical Association, 300, 2638 2646.
20. Kato, G.J., Martyr, S., Blackwelder, W.C., Nichols, J.S., Coles, W.A., Hunter, L.A., Brennan, M.L., Hazen, S.L. Gladwin, M.T. (2005) Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. British Journal of Haematology, 130, 943 953.
21. Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J.t., Morris, C.R., Nichols, J.S., Wang, X., Poljakovic, M., Morris, Jr., S.M. Gladwin, M.T. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood, 107, 2279 2285.
22. Kato, G.J., Gladwin, M.T. Steinberg, M.H. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews, 21, 37 47.
23. Kato, G.J., Wang, Z., Machado, R.F., Blackwelder, W.C., Taylor, J.G.t. Hazen, S.L. (2009) Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology, 145, 506 513.
24. Kaul, D.K., Liu, X.D., Fabry, M.E. Nagel, R.L. (2000) Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. American Journal of Physiology. Heart and Circulatory Physiology, 278, H1799 H1806.
25. Khovidhunkit, W., Kim, M.S., Memon, R.A., Shigenaga, J.K., Moser, A.H., Feingold, K.R. Grunfeld, C. (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. Journal of Lipid Research, 45, 1169 1196.
26. Kuypers, F.A. (2008) Red cell membrane lipids in hemoglobinopathies. Current Molecular Medicine, 8, 633 638.
27. Landburg, P.P., Teerlink, T., Muskiet, F.A., Duits, A.J. Schnog, J.J. (2008) Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis. American Journal of Hematology, 83, 577 579.
28. Lane, T.A., Ballas, S.K. Burka, E.R. (1976) Lipid synthesis in human erythroid cells: the effect of sickling. Blood, 47, 189 195.
29. Manci, E.A., Culberson, D.E., Yang, Y.M., Gardner, T.M., Powell, R., Haynes, Jr., J., Shah, A.K. Mankad, V.N. (2003) Causes of death in sickle cell disease: an autopsy study. British Journal of Haematology, 123, 359 365.
30. Marzouki, Z.M. Khoja, S.M. (2003) Plasma and red blood cells membrane lipid concentration of sickle cell disease patients. Saudi Medical Journal, 24, 376 379.
31. Morris, Jr., S.M. (2007) Arginine metabolism: boundaries of our knowledge. Journal of Nutrition, 137, 1602S 1609S.
32. Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr., S.M. Gladwin, M.T. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. Journal of the American Medical Association, 294, 81 90.
33. Muskiet, F.D. Muskiet, F.A. (1984) Lipids, fatty acids and trace elements in plasma and erythrocytes of pediatric patients with homozygous sickle cell disease. Clinica Chimica Acta, 142, 1 10.
34. Nath, K.A., Shah, V., Haggard, J.J., Croatt, A.J., Smith, L.A., Hebbel, R.P. Katusic, Z.S. (2000) Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 279, R1949 R1955.
35. Ngogang, J., Mouray, H., Lebreton de Vonne, T. Raisonnier, A. (1989) Erythrocyte and plasma cholesterol exchange in sickle cell anemia. Clinica Chimica Acta, 179, 295 304.
36. O'Keefe, J.H., Gheewala, N.M. O'Keefe, J.O. (2008) Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. Journal of the American College of Cardiology, 51, 249 255.
37. Reaven, G. (2002) Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation, 106, 286 288.
38. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, III., R.O., Schechter, A.N. Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383 1389.
39. Ren, H., Ghebremeskel, K., Okpala, I., Ugochukwu, C.C., Crawford, M. Ibegbulam, O. (2006) Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS). Prostaglandins Leukotrienes and Essential Fatty Acids, 74, 1 6.
40. Rosenson, R.S. (2009) Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease. Cardiovascular Drugs and Therapy, 23, 93 101.
41. Sasaki, J., Waterman, M.R., Buchanan, G.R. Cottam, G.L. (1983) Plasma and erythrocyte lipids in sickle cell anaemia. Clinical and Laboratory Haematology, 5, 35 44.
42. Shores, J., Peterson, J., VanderJagt, D. Glew, R.H. (2003) Reduced cholesterol levels in African-American adults with sickle cell disease. Journal of the National Medical Association, 95, 813 817.
43. Siques, P., Brito, J., Leon-Velarde, F., Barrios, L., De La Cruz, J.J., Lopez, V. Herruzo, R. (2007) Hematological and lipid profile changes in sea-level natives after exposure to 3550-m altitude for 8 months. High Altitude Medicine & Biology, 8, 286 295.
44. Stone, W.L., Payne, P.H. Adebonojo, F.O. (1990) Plasma-vitamin E and low plasma lipoprotein levels in sickle cell anemia patients. Journal of the Association for Academic Minority Physicians, 1, 12 16.
45. Styles, L.A., Aarsman, A.J., Vichinsky, E.P. Kuypers, F.A. (2000) Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood, 96, 3276 3278.
46. Taylor, J.G.t., Ackah, D., Cobb, C., Orr, N., Percy, M.J., Sachdev, V., Machado, R., Castro, O., Kato, G.J., Chanock, S.J. Gladwin, M.T. (2008) Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. American Journal of Hematology, 83, 6 14.
47. Wang, L., Gill, R., Pedersen, T.L., Higgins, L.J., Newman, J.W. Rutledge, J.C. (2009) Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. Journal of Lipid Research, 50, 204 213.
48. Westerman, M.P. (1975) Hypocholesterolaemia and anaemia. British Journal of Haematology, 31, 87 94.
49. Westerman, M.P., Diloy-Puray, M. Streczyn, M. (1979) Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling. Biochimica et Biophysica Acta, 557, 149 155.
50. Yuditskaya, S., Tumblin, A., Hoehn, G.T., Wang, G., Drake, S.K., Xu, X., Ying, S., Chi, A.H., Remaley, A.T., Shen, R.F., Munson, P.J., Suffredini, A.F. Kato, G.J. (2009) Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood, 113, 1122 1128.